1. Home
  2. EVER vs BIOA Comparison

EVER vs BIOA Comparison

Compare EVER & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EverQuote Inc.

EVER

EverQuote Inc.

HOLD

Current Price

$19.88

Market Cap

571.6M

Sector

Technology

ML Signal

HOLD

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

HOLD

Current Price

$18.04

Market Cap

681.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVER
BIOA
Founded
2008
2015
Country
United States
United States
Employees
N/A
62
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
571.6M
681.9M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
EVER
BIOA
Price
$19.88
$18.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$27.00
$51.50
AVG Volume (30 Days)
617.6K
375.7K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
198.86
N/A
EPS
0.51
N/A
Revenue
$163,349,000.00
N/A
Revenue This Year
$14.73
$720.93
Revenue Next Year
$11.51
N/A
P/E Ratio
$38.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.88
$4.07
52 Week High
$28.73
$24.00

Technical Indicators

Market Signals
Indicator
EVER
BIOA
Relative Strength Index (RSI) 58.61 56.60
Support Level $19.20 $15.49
Resistance Level $20.17 $18.26
Average True Range (ATR) 1.11 1.03
MACD 0.01 0.09
Stochastic Oscillator 80.47 93.55

Price Performance

Historical Comparison
EVER
BIOA

About EVER EverQuote Inc.

EverQuote Inc operates an online marketplace for insurance shopping, connecting consumers with insurance providers, including carriers and agents. Its marketplace is powered by proprietary data and technology platform that delivers high-intent, pre-validated consumer referrals aligned with insurers underwriting and profitability requirements. The platform provides transparency and campaign management tools, enabling providers to evaluate marketing spend performance and manage return on investment. Consumers can visit insurance provider websites, engage by phone, or submit data to receive quotes. Services are free for consumers, and the company derives revenue principally from consumer inquiries sold as referrals to insurance providers. It derives a majority of revenue from Direct channels.

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

Share on Social Networks: